TrialBMC pharmacology & toxicology2012

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial.

Yanelda García-Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.